Based on the resounding success of last year’s inaugural 2 day program dedicated to Oligonucleotide CMC & Regulatory Strategies we will once again be adding this content to complement our established Oligonucleotide Discovery and Delivery conference. In addition, we deliver two in-depth symposiums focusing on Rare Disease Drug Development and NEW for 2020: AI in Drug Discovery and Development. Bringing together leading discovery scientists, developers, CMC experts, regulatory specialists and technology providers, OPT Congress provides a unique opportunity to discuss advances in next-generation oligonucleotide therapies throughout the drug development process. Attend in 2020 to optimize your drug design, delivery and performance, accelerate time to market and achieve commercial success.
MARCH 17-18, 2020
5th Annual Oligonucleotide Discovery and Delivery: Optimizing Design, Delivery and Performance
2nd Annual Oligonucleotide CMC and Regulatory Strategies: Accelerating Product Development and Commercial Success
MARCH 19, 2020
Inaugural Artificial Intelligence for Drug Discovery & Development: Applications From Drug Design to Clinical Trials
3rd Annual Rare Disease Drug Development: New Drug Modalities and Emerging Trends